Third Rock Ventures is a venture capital firm headquartered in Boston, Massachusetts. The firm was established by Kevin Starr, Mark Levin, and Robert Tepper in 2007. As of July 2019, Third Rock Ventures is managing an active portfolio of 34 companies and has sold off its ownership in 57 companies. The firm specializes in funding companies at the early stage of development, in the field of biotechnology. Third Rock ventures provided venture capital to MyoKardia, a company which focuses on genetic heart diseases, that went public in 2015.
Third Rock announces $616m Fund IV
An immunotherapy company developing therapies to cancer
A biopharmaceutical company that develops nanotherapeutic treatments for ocular diseases and other eye related conditions
Voyager Therapeutics is a biotechnology company founded in 2014 that is headquartered in Cambridge, Massachusetts developing gene therapies to treat neurological disorders.
A biotechnology company that develops Probodies, proteolytically-activated antibodies to treat cancer.
A company developing gene therapies for the treatment of genetic diseases and cancer.
Sage Therapeutics is a biopharmaceutical company founded by Douglas Covey and Steven Paul in 2010 and headquartered in Cambridge, Massachusetts focused on the discovery and development of medicines to address central nervous system disorders.
Editas Medicine is a genome editing company founded in 2013 that is using CRISPR technology to treat patients with genetically defined diseases.
Magenta Therapeutics is a biotechnology company using stem cells to develop cellular therapies for immune and blood-based diseases.
Foundation Medicine is a Cambridge, Massachusetts-based healthcare company.
A public american pharmaceutical company
Neon Therapeutics is a biotechnology company developing immunotherapies for treating cancer.
A biopharmaceutical company dedicated to the development of novel therapeutics in the field of Epigenetics
A biopharmaceutical company developing therapeutics for the treatment of metabolic disorders such as obesity
A company developing therapies for the treatment of cancer
A biopharmaceutical company developing treatments for sickle cell disease
A company developing enzyme-based products for the treatmnet of gastrointestinal disorders and rare diseases
A company that develops oral enzyme therapeutics for the treatment of metabolic and kidney disorders
A company developing protein homeostasis therapies for oncology, immunology, and inflammation cases
A company focused on the development of personalized cancer therapies
A pharmaceutical company developing therapeutics for the treatment of bladder diseases
A biopharmaceutical company that develops antibody-based therapeutics to treat cancer
A company developing oral protein therapeutics to treat metabolic diseases
A biotechnology company that develops topical treatment for nail fungal infections
Associated investment funds
Partner, Cheif Technology Officer
Elizabeth Kwo, MD
Partner, Chief Human Resources Officer
Documentaries, videos and podcasts